Phenotypic analysis of antigen-specific T lymphocytes JD Altman, PAH Moss, PJR Goulder, DH Barouch, ... Science 274 (5284), 94-96, 1996 | 4754 | 1996 |
T-cell antigen receptor genes and T-cell recognition MM Davis, PJ Bjorkman Nature 334 (6181), 395-402, 1988 | 4383 | 1988 |
The immunological synapse: a molecular machine controlling T cell activation A Grakoui, SK Bromley, C Sumen, MM Davis, AS Shaw, PM Allen, ... Science 285 (5425), 221-227, 1999 | 4119 | 1999 |
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins SM Hedrick, DI Cohen, EA Nielsen, MM Davis Nature 308 (5955), 149-153, 1984 | 1714 | 1984 |
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy L Fong, Y Hou, A Rivas, C Benike, A Yuen, GA Fisher, MM Davis, ... Proceedings of the National Academy of Sciences 98 (15), 8809-8814, 2001 | 1503 | 2001 |
miR-181a is an intrinsic modulator of T cell sensitivity and selection QJ Li, J Chau, PJR Ebert, G Sylvester, H Min, G Liu, R Braich, ... Cell 129 (1), 147-161, 2007 | 1477 | 2007 |
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients PP Lee, C Yee, PA Savage, L Fong, D Brockstedt, JS Weber, D Johnson, ... Nature medicine 5 (6), 677-685, 1999 | 1382 | 1999 |
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. RA Seder, WE Paul, MM Davis, B Fazekas de St Groth The Journal of experimental medicine 176 (4), 1091-1098, 1992 | 1325 | 1992 |
Ligand recognition by αβ T cell receptors MM Davis, JJ Boniface, Z Reich, D Lyons, J Hampl, B Arden, Y Chien Annual review of immunology 16 (1), 523-544, 1998 | 1308 | 1998 |
Clonal replacement of tumor-specific T cells following PD-1 blockade KE Yost, AT Satpathy, DK Wells, Y Qi, C Wang, R Kageyama, ... Nature medicine 25 (8), 1251-1259, 2019 | 1249 | 2019 |
The immunological synapse SK Bromley, WR Burack, KG Johnson, K Somersalo, TN Sims, C Sumen, ... Annual review of immunology 19 (1), 375-396, 2001 | 1247 | 2001 |
Organoid modeling of the tumor immune microenvironment JT Neal, X Li, J Zhu, V Giangarra, CL Grzeskowiak, J Ju, IH Liu, SH Chiou, ... Cell 175 (7), 1972-1988. e16, 2018 | 1224 | 2018 |
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH P Early, H Huang, M Davis, K Calame, L Hood Cell 19 (4), 981-992, 1980 | 1179 | 1980 |
Variation in the human immune system is largely driven by non-heritable influences P Brodin, V Jojic, T Gao, S Bhattacharya, CJL Angel, D Furman, ... Cell 160 (1), 37-47, 2015 | 1111 | 2015 |
Diversity in the CDR3 region of VH is sufficient for most antibody specificities JL Xu, MM Davis Immunity 13 (1), 37-45, 2000 | 1106 | 2000 |
Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways P Early, J Rogers, M Davis, K Calame, M Bond, R Wall, L Hood Cell 20 (2), 313-319, 1980 | 1095 | 1980 |
Direct observation of ligand recognition by T cells DJ Irvine, MA Purbhoo, M Krogsgaard, MM Davis Nature 419 (6909), 845-849, 2002 | 1044 | 2002 |
Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells CA Turner Jr, DH Mack, MM Davis Cell 77 (2), 297-306, 1994 | 1025 | 1994 |
Identifying specificity groups in the T cell receptor repertoire J Glanville, H Huang, A Nau, O Hatton, LE Wagar, F Rubelt, X Ji, A Han, ... Nature 547 (7661), 94-98, 2017 | 968 | 2017 |
Multiple early factors anticipate post-acute COVID-19 sequelae Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ... Cell 185 (5), 881-895. e20, 2022 | 967 | 2022 |